Millennium Grants GSK European Marking Rights to Integrilin®
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 50 (Table of Contents)
Published: 4 Aug-2004
DOI: 10.3833/pdr.v2004.i50.792 ISSN: 1756-7874
Section: Distribution & Marketing
Fulltext:
Abstract
Millennium granted GlaxoSmithKline the rights to commercialize the blood clot inhibitor Integrilin® in Europe...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS